Exam Details
Subject | clinical research and regulatory affairs | |
Paper | ||
Exam / Course | m.pharm | |
Department | ||
Organization | Gujarat Technological University | |
Position | ||
Exam Date | May, 2017 | |
City, State | gujarat, ahmedabad |
Question Paper
Seat No.: Enrolment No.
GUJARAT TECHNOLOGICAL UNIVERSITY
M. Pharm- SEMESTER- II EXAMINATION SUMMER 2017
Subject Code: 2920206 Date: 31/05/2017
Subject Name: Clinical Research and Regulatory Affairs
Time: 10:30 AM to 01:30 PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Discuss concept of Para I to IV in ANDA.
06
Describe in brief the various principles of GCP
05
Write a short note on clinical trial protocol
05
Q.2
Classify NDA. Discuss regulatory requirements for NDA.
06
Discuss the responsibilities of investigator in a clinical trial.
05
Write a short note on informed consent process.
05
Q.3
Discuss the contents of Investigator's Brochure.
06
Write a note on composition of IRB/IEC.
05
Discuss the contents of clinical trial report.
05
Q.4
Discuss various phases of clinical trials.
06
Enlist the various essential documents required before the clinical trial is initiated and their location.
05
Write a short note on review procedure of IEC.
05
Q.5
Discuss in brief about the drug discovery process.
06
Write a note on data management in clinical research.
05
Write a note on sampling in clinical trials.
05
Q. 6
Write a short note on CRF.
06
Write a short note on quality assurance in clinical research.
05
Explain different methods for post marketing surveillance.
05
Q.7
Discuss study conduct methodology of BE study.
06
Discuss historical evolution of GCP guidelines.
05
Explain the process of obtaining approval for clinical trial as per Schedule Y in India.
05
GUJARAT TECHNOLOGICAL UNIVERSITY
M. Pharm- SEMESTER- II EXAMINATION SUMMER 2017
Subject Code: 2920206 Date: 31/05/2017
Subject Name: Clinical Research and Regulatory Affairs
Time: 10:30 AM to 01:30 PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Discuss concept of Para I to IV in ANDA.
06
Describe in brief the various principles of GCP
05
Write a short note on clinical trial protocol
05
Q.2
Classify NDA. Discuss regulatory requirements for NDA.
06
Discuss the responsibilities of investigator in a clinical trial.
05
Write a short note on informed consent process.
05
Q.3
Discuss the contents of Investigator's Brochure.
06
Write a note on composition of IRB/IEC.
05
Discuss the contents of clinical trial report.
05
Q.4
Discuss various phases of clinical trials.
06
Enlist the various essential documents required before the clinical trial is initiated and their location.
05
Write a short note on review procedure of IEC.
05
Q.5
Discuss in brief about the drug discovery process.
06
Write a note on data management in clinical research.
05
Write a note on sampling in clinical trials.
05
Q. 6
Write a short note on CRF.
06
Write a short note on quality assurance in clinical research.
05
Explain different methods for post marketing surveillance.
05
Q.7
Discuss study conduct methodology of BE study.
06
Discuss historical evolution of GCP guidelines.
05
Explain the process of obtaining approval for clinical trial as per Schedule Y in India.
05
Other Question Papers
Subjects
- advanced medicinal chemistry
- advanced organic chemistry-i
- advanced organic chemistry-ii
- advanced pharmacology ii
- advanced pharmacology-i
- advances in drug delivery system
- advances in pharmacology
- applied pharmacotherapeutics - ii
- applied pharmacotherapeutics-i
- audits and regulatory compliance
- biological evaluations & clinical research
- cellular and molecular pharmacology
- clinical and hospital pharmacy
- clinical pharmacy practice
- clinical research and pharmacy practice
- clinical research and regulatory affairs
- clinical research regulations
- cosmetic and cosmeceuticals
- documentation and regulatory writing
- drug design and discovery
- drug regulation and regulatory authority
- experimental design and patents
- global regulatory requirements
- gmp, glp and validation
- good manufacturing and good laboratory practice
- good manufacturing practice and process validation
- good regulatory practices
- hazards and safety management
- industrial pharmacy practice
- modern analytical techniques
- modern pharmaceutical analysis
- novel drug delivery system part-i
- novel drug delivery system-ii
- pharm. management -ii
- pharmaceutical analysis ii
- pharmaceutical and cosmetic analysis
- pharmaceutical formulation and development
- pharmaceutical formulation development and biopharmceutics
- pharmaceutical manufacturing technology
- pharmaceutical production management & technology
- pharmaceutical regulatory affairs
- pharmacological and toxicological screening methods-i
- pharmacological and toxicological screening methods-ii
- pharmacometrics and methods of biological evaluation of drugs
- pharmacotherapeutics
- principles of biopharmaceutics& pharmacokinetics
- product development and technology transfer
- quality control & quality assurance
- quality control and quality assurance
- quality management system
- regulatory affairs - i
- regulatory affairs and new drug applications
- regulatory aspects of hebbal and biologicals
- research methodology
- validation and product development